title: [Heart failure].
authors: Universitätsklinikum Düsseldorf, Klinik für Kardiologie, Pneumologie, Angiologie, 40225 Düsseldorf. Marc.Merx@med.uni-duesseldorf.de
authors: M W
authors: MW
authors: Merx
authors: G
authors: G
authors: Ertl
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D001552:Benzazepines / Q000009:adverse effects / Q000627:therapeutic use; D058406:Cardiac Resynchronization Therapy; D003131:Combined Modality Therapy; D054815:Cyclic Nucleotide-Gated Cation Channels / Q000187:drug effects; D000077545:Eplerenone; D006333:Heart Failure / Q000209:etiology / Q000401:mortality / Q000628:therapy*; D006339:Heart Rate / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D000077550:Ivabradine; D000451:Mineralocorticoid Receptor Antagonists / Q000009:adverse effects / Q000627:therapeutic use; D013148:Spironolactone / Q000009:adverse effects / Q000031:analogs & derivatives / Q000627:therapeutic use; D013318:Stroke Volume / Q000187:drug effects; D015996:Survival Rate
chemical_list: D000319:Adrenergic beta-Antagonists; D000889:Anti-Arrhythmia Agents; D001552:Benzazepines; D054815:Cyclic Nucleotide-Gated Cation Channels; D000451:Mineralocorticoid Receptor Antagonists; D013148:Spironolactone; D000077550:Ivabradine; D000077545:Eplerenone